How to Know If You Have Visceral Fat

Knowing how to tell if you have visceral fat is an important step in protecting your long-term health. Visceral fat sits deep within the abdominal cavity, surrounding vital organs, and unlike the fat you can pinch at your waist, it cannot be seen or felt directly. It is metabolically active and linked to serious conditions including type 2 diabetes, cardiovascular disease and fatty liver disease. This article explains what visceral fat is, how to assess your own risk using simple home measurements, what the clinical thresholds mean, and when to seek advice from a GP.

What is visceral fat and why does it matter for your health?

Visceral fat is stored deep in the abdominal cavity around vital organs and is more metabolically harmful than subcutaneous fat, releasing inflammatory chemicals linked to insulin resistance, raised blood pressure and elevated triglycerides.

Visceral fat is the fat stored deep within the abdominal cavity, surrounding organs such as the liver, pancreas and intestines, and it is metabolically more active and more harmful than the subcutaneous fat that sits just beneath the skin. Unlike the fat you can pinch at your waist, visceral fat cannot be seen or felt directly, which is why many people are unaware they carry excess amounts of it. It is sometimes referred to as "active fat" because it releases hormones and inflammatory chemicals that can disrupt normal metabolic processes.

The reason visceral fat matters so much for health is that its proximity to vital organs means the substances it releases enter the portal circulation and reach the liver directly. This is associated with insulin resistance, raised blood glucose, elevated triglycerides and increased blood pressure. People with a healthy overall body weight can still carry clinically significant amounts of visceral fat, a pattern sometimes described as normal-weight obesity or a metabolically obese normal-weight phenotype.

Visceral fat accumulation is influenced by a combination of genetics, diet, physical activity levels, sleep quality, stress and hormonal factors. Cortisol, the stress hormone, is particularly associated with central fat deposition.^[11][12] Age also plays a role: as people get older, fat tends to redistribute from the limbs and periphery towards the abdomen, even when total body weight remains stable. Understanding what visceral fat is and why it differs from other body fat is the first step towards assessing your own risk.

How can you tell if you have too much visceral fat?

Combining waist circumference with BMI and waist-to-height ratio gives the best practical indication, as a waist below half your height in centimetres is associated with lower cardiometabolic risk.

You can get a reasonable indication of whether you carry excess visceral fat by combining a simple waist measurement with your body mass index (BMI), although no single home measurement gives a definitive answer. Visceral fat cannot be measured directly without specialist imaging such as a CT scan or MRI, which are not used routinely in primary care for this purpose. Several practical proxies are used in clinical practice and are recognised by organisations including NICE and the NHS.

BMI is a widely used starting point. According to NHS guidance, a BMI of 25 to 29.9 is classified as overweight and 30 or above as obese. However, BMI does not distinguish between fat and muscle, nor does it indicate where fat is stored. Two people with identical BMIs can have very different amounts of visceral fat depending on their body composition and fat distribution. For this reason, waist circumference is considered a more direct indicator of central adiposity.

Waist-to-height ratio is another useful tool. NICE has recommended that a waist circumference of less than half your height is a useful indicator of lower risk.^[4][3] For example, a person who is 170 cm tall should ideally have a waist measurement below 85 cm. Some clinicians also use the waist-to-hip ratio, which compares the circumference of the waist to that of the hips. According to the WHO Expert Consultation on waist circumference and waist-to-hip ratio, a ratio above 0.90 in men and above 0.85 in women is associated with increased cardiometabolic risk. Using these measures together gives a more complete picture than any single figure alone.

Waist measurement and other simple checks you can do at home

Measure your waist at the midpoint between your lowest rib and hip bone after a gentle exhalation; NHS thresholds flag high risk at 102 cm or above in men and 88 cm or above in women.

Measuring your waist accurately at home is straightforward and requires only a flexible tape measure. Stand upright, breathe out gently, and place the tape around your bare abdomen at the midpoint between the bottom of your lowest rib and the top of your hip bone (iliac crest), keeping it horizontal and snug but not compressing the skin. Take the reading at the end of a normal exhalation, not after sucking in your stomach. This midpoint method is the technique recommended by the WHO and used in NHS clinical practice.

NHS guidance identifies the following thresholds as indicating increased health risk:

• Men: a waist measurement of 94 cm (approximately 37 inches) or above indicates increased risk; 102 cm (approximately 40 inches) or above indicates high risk.

• Women: a waist measurement of 80 cm (approximately 31.5 inches) or above indicates increased risk; 88 cm (approximately 34.5 inches) or above indicates high risk.

It is worth noting that these thresholds were largely derived from studies in white European populations. NICE guidance acknowledges that people of South Asian, Chinese, Japanese and Black African or Caribbean descent may face equivalent metabolic risks at lower waist circumference values.^[3][5] For these groups, lower action thresholds are sometimes applied clinically. NICE also recommends using lower BMI thresholds to define overweight (23 kg/m2) and obesity (27.5 kg/m2) for people of South Asian, Chinese, and Black African or Caribbean descent, reflecting their higher risk of metabolic complications at a given BMI.

Beyond waist measurement, some consumer body composition scales claim to estimate visceral fat using bioelectrical impedance analysis (BIA). While these devices can provide a rough indication, their accuracy varies considerably depending on hydration status, the time of day and the quality of the device. They should be treated as a general guide rather than a clinical measurement. If you are concerned about your results, a GP can arrange more formal assessment and, where appropriate, refer you for further investigation.

What health risks are linked to high levels of visceral fat?

High visceral fat significantly raises the risk of type 2 diabetes, cardiovascular disease, NAFLD and certain cancers, largely through chronic low-grade inflammation and impaired insulin sensitivity.

High levels of visceral fat are associated with a significantly increased risk of several serious long-term conditions, including type 2 diabetes, cardiovascular disease, non-alcoholic fatty liver disease (NAFLD), certain cancers and obstructive sleep apnoea. The inflammatory proteins and free fatty acids released by visceral fat tissue contribute to a state of chronic low-grade inflammation, which underpins many of these conditions.

In terms of cardiovascular risk, excess visceral fat is linked to raised LDL cholesterol, lower HDL cholesterol, elevated triglycerides and higher blood pressure, a cluster of abnormalities sometimes called metabolic syndrome.^[6][16] NICE guidance on cardiovascular disease risk identifies central adiposity as an independent risk factor for cardiovascular disease, separate from overall body weight.^[6] People with metabolic syndrome have a higher risk of heart attack and stroke compared with those who do not, though the precise magnitude of risk varies depending on the combination of factors present.

The relationship between visceral fat and type 2 diabetes is particularly well established. Visceral fat impairs the body's response to insulin, meaning the pancreas must produce more insulin to maintain normal blood glucose levels. Over time, this can lead to beta-cell exhaustion and the development of type 2 diabetes. Research, including evidence reviewed by the World Cancer Research Fund, also suggests that excess body fatness is associated with an increased risk of certain cancers, including colorectal, breast and endometrial cancer, though the mechanisms continue to be investigated.

Importantly, even modest reductions in visceral fat, achieved through dietary changes and increased physical activity, can produce meaningful improvements in metabolic markers. Evidence suggests that reductions in waist circumference are associated with improvements in blood pressure, insulin sensitivity and inflammatory markers, making early action worthwhile.

When should you speak to a GP about your weight or belly fat?

See a GP if your waist exceeds high-risk thresholds, you have metabolic risk factors, or you experience symptoms such as fatigue, increased thirst or frequent urination that may indicate type 2 diabetes or cardiovascular disease.

You should speak to a GP if your waist measurement exceeds the high-risk thresholds described above, if you have noticed a significant increase in abdominal girth over a short period, or if you have other risk factors for metabolic disease such as a family history of type 2 diabetes, high blood pressure or cardiovascular disease. A GP can carry out a full assessment, including blood tests to check HbA1c (the primary UK diagnostic test for type 2 diabetes, as recommended by NICE), fasting lipid profile, liver function and blood pressure, which together give a much clearer picture of your cardiometabolic risk than waist measurement alone.^[7]

You should also seek a GP appointment if you are experiencing symptoms that may be related to metabolic complications, such as persistent fatigue, increased thirst, frequent urination, or shortness of breath on mild exertion, as these can be early signs of conditions such as type 2 diabetes or cardiovascular disease that warrant prompt investigation.

Seek urgent or same-day medical attention if you experience sudden or rapidly worsening abdominal swelling accompanied by symptoms such as pain, jaundice (yellowing of the skin or eyes), fever, unexplained weight loss, or severe breathlessness. These symptoms are not typical of visceral fat alone and may indicate a condition requiring prompt assessment.

For people who meet specific clinical criteria, NICE technology appraisals have recommended certain weight management medicines for use within specialist NHS services. Access to these treatments is determined by your local Integrated Care Board (ICB) and depends on individual clinical circumstances, not simply on BMI or waist measurement alone. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, where a range of clinically appropriate options may be considered.

If you are unsure whether your concerns warrant a GP visit, NHS 111 can provide guidance. You may also be eligible for an NHS Health Check, which assesses your risk of heart disease, stroke, diabetes and kidney disease and is offered to adults in England aged 40 to 74.^[2] Lifestyle interventions, including a balanced diet, regular aerobic and resistance exercise, improved sleep and stress management, remain the foundation of visceral fat reduction and should be discussed with a healthcare professional who can tailor advice to your individual circumstances.

Scientific References

1. Overweight and obesity in adults.
2. NHS Health Check.
3. Overweight and obesity management (NG246) – Identifying and assessing overweight, obesity and central adiposity.
4. Keep the size of your waist to less than half of your height – NICE recommends.
5. Appendix A1: Summary of evidence from surveillance (NG246).
6. Cardiovascular disease: risk assessment and reduction (NG238).
7. Blood glucose management – Type 2 diabetes in adults (NG28).
8. About technology appraisal guidance.
9. A causative link between visceral adiposity and hepatic insulin resistance.
10. Waist circumference as a measure for indicating need for weight management.
11. Stress-induced cortisol response and fat distribution in women.
12. Do stress reactions cause abdominal obesity and comorbidities?.
13. The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis.
14. Is visceral obesity a physiological adaptation to stress?.
15. Crosstalk between visceral adipose tissue secretome and tumoral microenvironment in obesity-induced colorectal cancer.
16. Male Obesity and Cardiometabolic Risk: Inflammatory Mechanisms and Clinical Implications.
17. Disrupting the adiposopathy-inflammation loop: a translational immunometabolic framework for inflammatory disease.

Frequently Asked Questions